相似文献
1
Association of High-Density Lipoprotein Cholesterol With Sex Steroid Treatment in Transgender and Gender-Diverse Youth.
JAMA Pediatr. 2021 May 1;175(5):520-521. doi: 10.1001/jamapediatrics.2020.5620.
2
Lipid profile and risk of cardiovascular disease in adult transgender men receiving cross-sex hormone therapy: a systematic review.
Nutr Rev. 2023 Sep 11;81(10):1310-1320. doi: 10.1093/nutrit/nuad003.
3
Sex steroids, lipids, and lipoprotein cholesterols in women with subclinical and overt hypothyroidism before and after L-thyroxine therapy.
Clin Chim Acta. 1998 Jul 6;275(1):81-91. doi: 10.1016/s0009-8981(98)00074-6.
4
Lipoprotein metabolism in postmenopausal and oophorectomized women.
Obstet Gynecol. 1995 Apr;85(4):523-8. doi: 10.1016/0029-7844(94)00452-J.
5
6
Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control.
Am J Cardiol. 2010 Sep 15;106(6):757-63. doi: 10.1016/j.amjcard.2010.05.002. Epub 2010 Aug 1.
7
Interpreting laboratory results in transgender patients on hormone therapy.
Am J Med. 2014 Feb;127(2):159-62. doi: 10.1016/j.amjmed.2013.10.009. Epub 2013 Oct 19.
8
Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
J Am Coll Cardiol. 2009 Dec 29;55(1):35-41. doi: 10.1016/j.jacc.2009.07.057.
9
Metabolic effects of cross-sex hormone therapy in transgender individuals in Taiwan.
J Chin Med Assoc. 2021 Mar 1;84(3):267-272. doi: 10.1097/JCMA.0000000000000475.
10
Distinct Lipoprotein Curves in Normal Weight, Overweight, and Obese Children and Adolescents.
J Pediatr Gastroenterol Nutr. 2017 Dec;65(6):673-680. doi: 10.1097/MPG.0000000000001674.
引用本文的文献
1
Insulin sensitivity, body composition and bone mineral density after testosterone treatment in transgender youth with and without prior GnRH agonist therapy.
J Clin Transl Endocrinol. 2024 Jun 1;36:100356. doi: 10.1016/j.jcte.2024.100356. eCollection 2024 Jun.
2
Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data.
Br J Gen Pract. 2023 Jun 29;73(732):e486-e492. doi: 10.3399/BJGP.2023.0023. Print 2023 Jul.
3
Gender-Affirming Care of Transgender and Gender-Diverse Youth: Current Concepts.
Annu Rev Med. 2023 Jan 27;74:107-116. doi: 10.1146/annurev-med-043021-032007. Epub 2022 Oct 19.
4
Care for Transgender Young People.
Horm Res Paediatr. 2022;95(5):405-414. doi: 10.1159/000524030. Epub 2022 Mar 10.
5
The effect of gender-affirming hormone treatment on serum creatinine in transgender and gender-diverse youth: implications for estimating GFR.
Pediatr Nephrol. 2022 Sep;37(9):2141-2150. doi: 10.1007/s00467-022-05445-0. Epub 2022 Jan 26.
6
Lipoprotein subtypes after testosterone therapy in transmasculine adolescents.
J Clin Lipidol. 2021 Nov-Dec;15(6):840-844. doi: 10.1016/j.jacl.2021.09.051. Epub 2021 Oct 2.
7
Challenges in the care of transgender and gender-diverse youth: an endocrinologist's view.
Nat Rev Endocrinol. 2021 Oct;17(10):581-591. doi: 10.1038/s41574-021-00535-9. Epub 2021 Aug 10.
Zotero 插件